Cargando…

Proteomic profiling reveals that collismycin A is an iron chelator

Collismycin A (CMA), a microbial product, has anti-proliferative activity against cancer cells, but the mechanism of its action remains unknown. Here, we report the identification of the molecular target of CMA by ChemProteoBase, a proteome-based approach for drug target identification. ChemProteoBa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawatani, Makoto, Muroi, Makoto, Wada, Akira, Inoue, Gyo, Futamura, Yushi, Aono, Harumi, Shimizu, Kenshirou, Shimizu, Takeshi, Igarashi, Yasuhiro, Takahashi-Ando, Naoko, Osada, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138588/ https://www.ncbi.nlm.nih.gov/pubmed/27922079 http://dx.doi.org/10.1038/srep38385

Ejemplares similares

Inhibition of mitochondrial complex I by the novel compound FSL0260 enhances high salinity-stress tolerance in Arabidopsis thaliana
por: Sako, Kaori, et al.
Publicado: (2020)

Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival
por: Kawamura, Tatsuro, et al.
Publicado: (2016)

Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling
por: KAWATANI, MAKOTO, et al.
Publicado: (2023)

Isolation of new polyketide metabolites, linearolides A and B, from Streptomyces sp. RK95-74
por: Ueki, Masashi, et al.
Publicado: (2013)

Mitochondrial uncoupler exerts a synthetic lethal effect against β‐catenin mutant tumor cells
por: Shikata, Yuki, et al.
Publicado: (2017)

Glyoxalase I disruption and external carbonyl stress impair mitochondrial function in human induced pluripotent stem cells and derived neurons
por: Hara, Tomonori, et al.
Publicado: (2021)

cis-Decalin-containing tetramic acids as inhibitors of insect steroidogenic glutathione S-transferase Noppera-bo
por: Kato, Naoki, et al.
Publicado: (2023)

Discovery of the novel autophagy inhibitor aumitin that targets mitochondrial complex I
por: Robke, Lucas, et al.
Publicado: (2018)

Collismycin C from the Micronesian Marine Bacterium Streptomyces sp. MC025 Inhibits Staphylococcus aureus Biofilm Formation
por: Lee, Jin-Hyung, et al.
Publicado: (2017)

Caerulomycin and collismycin antibiotics share a trans-acting flavoprotein-dependent assembly line for 2,2’-bipyridine formation
por: Pang, Bo, et al.
Publicado: (2021)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine
por: Komoto, Kana, et al.
Publicado: (2020)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Anti-MRSA Activity of Actinomycin X(2) and Collismycin A Produced by Streptomyces globisporus WA5-2-37 From the Intestinal Tract of American Cockroach (Periplaneta americana)
por: Chen, Zhiyu, et al.
Publicado: (2020)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes
por: Shimizu, Yoichi, et al.
Publicado: (2021)

Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012)

Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent
por: Lee, Ji Won, et al.
Publicado: (2013)

Oxidation-Induced Degradable Nanogels for Iron Chelation
por: Liu, Zhi, et al.
Publicado: (2016)

The Utility of Iron Chelators in the Management of Inflammatory Disorders
por: Lehmann, C., et al.
Publicado: (2015)

Iron Chelation Resulting in Renal Phosphate Wasting
por: Cheddani, Lynda, et al.
Publicado: (2017)

Potential Treatment of Retinal Diseases with Iron Chelators
por: Shu, Wanting, et al.
Publicado: (2018)

Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020)

Conformational Stability Effect of Polymeric Iron Chelators
por: Qian, Jian, et al.
Publicado: (2019)

Adherence to Iron Chelation Therapy and Its Determinants
por: Sidhu, Sukhmani, et al.
Publicado: (2021)

Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
por: Zeng, Xiaoyan, et al.
Publicado: (2021)

The synthesis and properties of mitochondrial targeted iron chelators
por: Cilibrizzi, Agostino, et al.
Publicado: (2022)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0unr99lkfcnnrn12o2t0lmfr22